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Dysphagia is a common problem in elderly patients and a rare manifestation of Graves’ disease. We report a case of an 82-year-
old male who presented with a 4-week history of dysphagia and weight loss. Workup for his dysphagia with upper endoscopy,
MRI brain, electromyography, acetyl-cholinesterase receptor antibodies, and voltage-gated calcium channel antibodies were
negative. Modiﬁed Barium swallow test showed oropharyngeal dysphagia. Thyroid function tests that revealed hyperthyroidism
and antibodies to TSH-receptor were positive. Based on the above ﬁndings, we considered Graves’ disease as the most likely
diagnosis. Patient was treated with methimazole and beta-blockers and subsequently his dysphagia resolved. This paper highlights
the importance to clinicians of considering thyrotoxicosis as possible diagnosis in an elderly patient presenting with unexplained
dysphagia.
1.Introduction
In the elderly, the prevalence of hyperthyroidism is 0.2–2%
which is similar to general population and often present with
a subtle and unusual clinical pattern. The most common
symptoms and signs are anorexia, fatigue, weight loss, and
occasionally tachycardia [1]. Rarely, thyrotoxicosis can cause
bulbar muscle wasting, weakness, and resultant pharyngeal
or esophageal dysmotility, and the patient may present with
dysphagia [2].
2. Case Presentation
An 82-year-old white male presented to the emergency
department with a 4-week history of progressively wors-
ening diﬃculty swallowing liquids and solid food. Associ-
ated symptoms were hoarse voice and intermittent nasal
regurgitation. He also experienced 25 pounds weight loss
over the past 4 weeks, anorexia, generalized weakness, and
intermittent episodes of palpitations. He denied diplopia,
dysarthria, odynophagia, extremity weakness or numbness,
nausea,vomiting,diarrhea,andabdominalpain.Hismedical
history included coronary artery disease, angioplasty, and
stent placement in right coronary artery 10 years ago. He
quit smoking several years ago. He denied alcohol abuse or
IV drug use.
On physical examination the patient was alert, awake
but disoriented, and he appeared cachectic. The temper-
ature was 98.6F, blood pressure 170/90mm Hg, pulse
112 beats per minute, the respiratory rate 16, and the
oxygen saturation 95% while he was breathing room air.
Eye examination revealed lid lag without proptosis. The
thyroid was enlarged with palpable lower border, the left
lobe bigger than the right, had a granular consistency and
a bruit heard over the thyroid gland. S1 and S2 were
normal, with regular rhythm, tachycardic and his lungs clear
to auscultation. Neurological exam revealed mild weakness
in the hip ﬂexors bilaterally. There was resting tremor
of the hands bilaterally. Workup for dysphagia included
a modiﬁed barium swallow test which revealed severe
oropharyngeal dysphagia. Esophago-gastroscopy did not
reveal any abnormality. MRI of the brain showed small vessel
ischemic disease. Electromyography and creatinephosphoki-
naselevelwerenormal;antibodiestotheacetylcholinesterase
receptor and voltage-gated calcium channel were unde-
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Thyroid function tests showed TSH 0.005mIU/mL
(0.270–4.0), free T4 4.61ng/dL (0.90–1.80), total T3 2.68ng/
mL (0.80–2.0), total T4 17.2ug/dL (4.6–12), antithy-
roid peroxidase antibody (TPO) 298IU/mL (<4IU/mL),
and antithyroid stimulating immunoglobulin (TSI) 162%
(<125). (Estimation methods: chemiluminescent immuno-
assay for TSH, free T4, total T4, total T3, and enzyme-
linked immunosorbent assay –ELISA for Anti-TPO, Anti-
TSI.) Thyroid ultrasound revealed diﬀuse heterogeneous
multiple ill-deﬁned nodules, and thyroid size was within the
normal limits.
Based on the history, clinical ﬁndings, and laboratory
data, we considered Graves’ disease as the most likely
diagnosis. Patient was treated with methimazole 10mg three
times daily and propranolol 20mg every 6 hours. Five days
later, the patient was tolerating liquids and a soft diet. Four
weeks after, his symptoms completely resolved and thyroid
function tests showed TSH 0.005mIU/mL (0.270–4.0) and
free T4 1.94ng/dL (0.90–1.80).
3. Discussion
Dysphagia is a common problem in elderly persons. Possible
causes are stroke, Parkinson’s disease, esophageal carcinoma,
thyroid disease, Zenker’s diverticulum, myasthenia gravis,
diabetes mellitus, and polymyositis [3]. In cases where
thyroid disease is thought to cause dysphagia, the most likely
mechanism is an enlarging cervical or retrosternal goiter
which causes direct impingement of esophagus. However
thyrotoxicosis can cause muscle weakness, rarely aﬀecting
the bulbar muscles and triggering dysphagia. Classic mus-
culoskeletal ﬁndings of thyrotoxicosis are painless skeletal
muscle wasting, with normal muscle enzymes and nonspe-
ciﬁc electromyographic abnormalities [4]. More than 50% of
patients with hyperthyroidism complain of muscle weakness
and 63% had evidence of proximal muscle weakness or
wasting [5]. When thyrotoxicosis causes bulbar muscle
wasting and resultant oropharyngeal or esophageal dys-
motility, the patient may present with dysphagia, dysarthria,
and dysphonia [6]. Most of the patients with dysphagia
experienced preceding muscle weakness but rarely may
develop a sudden onset bulbar muscle paresis [2]. A possible
mechanism is a direct eﬀect of thyroid hormones on
neuromuscular transmission causing disturbances in the
neuromuscular function and oropharyngeal peristalsis [7,
8]. Evidence that beta-blockers ameliorate muscle weak-
ness in patients with hyperthyroidism suggests that beta-
adrenergic stimulation contributes to clinical myopathy [9].
In the elderly, the prevalence of hyperthyroidism is 1-
2%, and often presents with anorexia, fatigue, weight loss,
and occasionally tachycardia [3]. Because it is unusual for
thyrotoxicosis to cause dysphagia, it is important to rule
out other causes of dysphagia. Such a work up might
include modiﬁed barium swallow test, upper endoscopy,
MRI of the brain, electromyography, acetyl-cholinesterase
receptor antibodies, and voltage-gated calcium channel
antibodies. The work up in our case suggested the diagnosis
of Graves’ disease, the most common cause of hyperthy-
roidism.
The treatment of choice is antithyroid agents such as
methimazole, with goal restoring euthyroid state. Additional
symptom control can be achieved with addition of beta-
blockers like propranolol or atenolol [10]. Dysphagia will
resolve within few to several weeks following treatment and
has a good prognosis [6]. Radioactive iodine therapy is
a treatment option, when patient attains euthyroid state.
Surgical thyroidectomy is less preferable option due to
the multiple chronic medical conditions especially cardiac
problems in elderly patients.
4. Conclusion
We present an interesting case of a patient who presented
with dysphagia, hoarseness, and nasal regurgitation caused
by bulbar myopathy associated with Graves’ disease. Hyper-
thyroidism in the elderly often presents atypically and is
easily missed, yet treatment is highly eﬀective. This case
report highlights thyrotoxicosis as a possible diagnosis in
an elderly patient presenting with unexplained dysphagia.
We recommend thyroid functions tests as part of diagnostic
work up for dysphagia to rule out hyperthyroidism.
Conﬂict of Interests
All authors verify their mutual agreement to submit this
paper to this journal for review, that this work has not be
submitted to any other journals for consideration and that
neither the author himself or the other authors have any
potential conﬂict of interests to declare with regards to this
paper. The ﬁnal paper has been seen and approved by all
authors.
References
[1] C. Trivalle, J. Doucet, P. Chassagne et al., “Diﬀerences in the
signs and symptoms of hyperthyroidism in older and younger
patients,”JournaloftheAmericanGeriatricsSociety,vol.44,no.
1, pp. 50–53, 1996.
[2] G. M. Kammer and C. R. Hamilton Jr., “Acute bulbar muscle
dysfunction and hyperthyroidism. A study of four cases and
review of the literature,” American Journal of Medicine, vol. 56,
no. 4, pp. 464–470, 1974.
[3] S. R. Achem and K. R. DeVault, “Dysphagia in aging,” Journal
of Clinical Gastroenterology, vol. 39, no. 5, pp. 357–371, 2005.
[4] R. F. Duyﬀ,J .v a nd e nB o s c h ,D .M .L a m a n ,B .J .P .v a n
Loon,andW.H.J.P.Linssen,“Neuromuscularﬁndingsinthy-
roid dysfunction: a prospective clinical and electrodiagnostic
study,” Journal of Neurology Neurosurgery and Psychiatry, vol.
68, no. 6, pp. 750–755, 2000.
[5] I. D. Ramsay, “Muscle dysfunction in hyperthyroidism,” The
Lancet, vol. 2, no. 7470, pp. 931–934, 1966.
[6] W. Y. Chiu, C. C. Yang, I. C. Huang, and T. S. Huang,
“Dysphagia as a manifestation of thyrotoxicosis: report of
three cases and literature review,” Dysphagia, vol. 19, no. 2, pp.
120–124, 2004.
[7] H. Noto, T. Mitsuhashi, S. Ishibashi, and S. Kimura, “Hyper-
thyroidism presenting as dysphagia,” Internal Medicine, vol.
39, no. 6, pp. 472–473, 2000.Case Reports in Medicine 3
[8] A. Alshekhlee, H. J. Kaminski, and R. L. Ruﬀ, “Neuromuscular
manifestations ofendocrinedisorders,” Neurologic Clinics,vol.
20, no. 1, pp. 35–58, 2002.
[9] I. Klein and K. Ojamaa, “Thyroid (neuro)myopathy,” The
Lancet, vol. 356, no. 9230, p. 614, 2000.
[10] G. A. Brent, “Clinical practice. Graves’ disease,” The New
England Journal of Medicine, vol. 358, no. 24, pp. 2594–2605,
2008.